Literature DB >> 2549488

Characterization of alternate and truncated forms of murine c-myb proteins.

R G Ramsay1, S Ishii, Y Nishina, G Soe, T J Gonda.   

Abstract

The expression of c-myb proteins in transformed and normal murine cells was investigated. Two c-myb proteins, p75c-myb and p90c-myb, were detected in normal thymocytes and cell lines with intact c-myb genes. These most likely differ by the inclusion of additional amino acids encoded by an alternatively spliced c-myb mRNA. The use of this alternative exon is therefore not a feature exclusively of those cells with viral integrations in their c-myb gene. Smaller c-myb proteins in myeloid leukemic cell lines with rearranged c-myb genes were also characterized. Viral integration into the 5' region of the c-myb gene in the W265 and W274 cell lines leads to the synthesis in each case of two amino-terminally truncated c-myb proteins. By contrast, in NFS60 cells, viral integration into a more 3' region of the c-myb locus (but upstream of an alternate exon) leads to the production of a single p50c-myb protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549488

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  27 in total

1.  Phosphorylation of the retinoblastoma protein by cdk2.

Authors:  T Akiyama; T Ohuchi; S Sumida; K Matsumoto; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.

Authors:  L Wolff; R Koller; W Davidson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.

Authors:  Ren-Ming Yang; Devathri Nanayakkara; Murugan Kalimutho; Partha Mitra; Kum Kum Khanna; Eloise Dray; Thomas J Gonda
Journal:  Oncogene       Date:  2019-04-10       Impact factor: 9.867

5.  c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Authors:  A Biroccio; B Benassi; I D'Agnano; C D'Angelo; S Buglioni; M Mottolese; A Ricciotti; G Citro; M Cosimelli; R G Ramsay; B Calabretta; G Zupi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Authors:  A E Cuddihy; L A Brents; N Aziz; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling.

Authors:  Marina R Carpinelli; Douglas J Hilton; Donald Metcalf; Jennifer L Antonchuk; Craig D Hyland; Sandra L Mifsud; Ladina Di Rago; Adrienne A Hilton; Tracy A Willson; Andrew W Roberts; Robert G Ramsay; Nicos A Nicola; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

8.  New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.

Authors:  R Mukhopadhyaya; L Wolff
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  MYB suppresses differentiation and apoptosis of human breast cancer cells.

Authors:  Yvette Drabsch; Ramsay G Robert; Thomas J Gonda
Journal:  Breast Cancer Res       Date:  2010-07-26       Impact factor: 6.466

10.  Protein truncation is not required for c-myb proto-oncogene activity in neuroretina cells.

Authors:  C Garrido; F Grässer; J S Lipsick; D Stehelin; S Saule
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.